# Steroid Sparing in Immune Related Hepatitis (irH)

> **NCT05345847** · NA · RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 56 (estimated)

## Conditions studied

- Hepatitis Immune

## Interventions

- **OTHER:** Active Surveillance
- **OTHER:** Early initiation

## Key facts

- **NCT ID:** NCT05345847
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-08
- **Primary completion:** 2028-02-08
- **Final completion:** 2029-02-08
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05345847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05345847, "Steroid Sparing in Immune Related Hepatitis (irH)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05345847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*